Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zhang, Yanqiong ^a   Yan, Chen ^a,b   Li, Yuting ^a   Mao, Xia ^a   Tao, Weiwei ^c   Tang, Yuping ^c   Lin, Ya ^d   Guo, Qiuyan ^a   Duan, Jingao ^c   Lin, Na ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AQP4 PROTEIN, MOUSE; AQUAPORIN 4; ARHGDIB PROTEIN, MOUSE; FRK PROTEIN, MOUSE; INPP5D PROTEIN, MOUSE; MINOR HISTOCOMPATIBILITY ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 5 PHOSPHATASE; PLANT EXTRACT; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; TUMOR MARKER; VASOPRESSIN RECEPTOR;

ANIMAL; ASCITES; CHEMISTRY; DRUG EFFECT; EUPHORBIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLYCYRRHIZA; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; AQUAPORIN 4; ASCITES; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; EUPHORBIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCYRRHIZA; LIVER NEOPLASMS; MALE; MICE; MINOR HISTOCOMPATIBILITY ANTIGENS; PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE 5-PHOSPHATASES; PLANT EXTRACTS; RECEPTORS, VASOPRESSIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; SRC-FAMILY KINASES;

EID: 85011827070     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41925     Document Type: Article

References (51)

1. Yoshiji, H. et al. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model. Hepatology 33, 841-7 (2001).
2. Ayantunde, A. A. & Parsons, S. L. Pattern and prognostic factors in patients with malignant ascites: A retrospective study. Ann Oncol. 18, 945-9 (2007).
3. Garrison, R. N., Kaelin, L. D., Galloway, R. H. & Heuser, L. S. Malignant ascites: clinical and experimental observations. Ann Surg 203, 644-651 (1986).
4. Jia, W., et al. Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil. Cancer Chemother Pharmacol. 71, 1585-90 (2013).
5. Saif, M. W., Siddiqui, I. A. & Sohail, M. A. Management of ascites due to gastrointestinal malignancy. Ann Saudi Med. 29, 369-77 (2009).
6. Aslam, N. & Marino, C. R. Malignant ascites: new concepts in pathophysiology, diagnosis, and management. Intern Med. 161, 2733-7 (2001).
7. Li, S., Zhang, B., Jiang, D., Wei, Y. & Zhang, N. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 11, Suppl 11, S6 (2010).
8. Luo, Y. H. Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of cirrhotic ascites: A report of54cases. Hunan Journal of Traditional Chinese Medicne 29, (In Chinese), 20-2 (2013).
9. He, N. Y. Clinical observations of the external application of Jidai formula and thermal therapy in the treatment of malignant ascites in 25 cases. Hebei Journal of Traditional Chinese Medicine 37, 190-1 (2015).
10. Mucsi, I., Molnar, J., Hohmann, J. & Redei, D. Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated fromEuphorbiaspecies. Planta Med 67, 672-4 (2001).
11. Chen, J., Jin, X., Chen, J. & Liu, C. Glycyrrhiza polysaccharide induces apoptosis and inhibits proliferation of human hepatocellular carcinoma cells by blocking PI3K/AKT signal pathway. Tumour Biol. 34, 1381-9 (2013).
12. Wang, D. et al. Liquiritigenin Induces Tumor Cell Death through Mitogen-Activated Protein Kinase-(MPAKs-) Mediated Pathway in Hepatocellular Carcinoma Cells. Biomed Res Int. 2014, 965316 (2014).
13. Hsieh, M. J., Lin, C. W., Yang, S. F., Chen, M. K. & Chiou, H. L. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-B and AP-1 activity in human liver cancer cells. Br J Pharmacol. 171, 3037-50 (2014).
14. Xia, J. Y. & Yan, T. C. The treatment of Refractory ascites due to cirrhosis in 40 cases by the combination of multiple methods. Heilongjiang Journal of Traditional Chinese Medicine 3, 29-30, (In Chinese) (1999).
15. Ye, L., Fan, X. S., Duan, J. A., Shang, E. X. & Guo, S. The analysis of combinational rules and application characteristics of Chinese medicines Euphorbia with toxicity. Information on Traditional Chinese Medicine 26, (In Chinese), 23-5 (2009).
16. Xue, H. G., Zhou, S. D., He, X. J. & Yu, Y. Molecular authentication of the traditional Chinese medicinal plant Euphorbia pekinensis. Planta Med. 73, 91-3 (2007).
17. Kitano, H. A robustness-based approach to systems oriented drug design. Nat Rev Drug Discov. 6, 202-10 (2007).
18. Zhang, Y. et al. Pathway of PPAR-gamma coactivators in thermogenesis: A pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis. Oncotarget. In press, doi: 10. 18632/oncotarget. 7419 (2016).
19. Zhang, Y. et al. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep. 5, 9463 (2015).
20. Zhang, Y. et al. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis. Evid Based Complement Alternat Med. 2013, 548498 (2013).
21. Zhang, Y. et al. Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation. Int J Biol Sci 12, 594-606 (2016).
22. Guo, Q. et al. A Systems Biology Perspective on the Molecular Mechanisms Underlying the Therapeutic Effects of Buyang Huanwu Decoction on Ischemic Stroke. Rejuvenation Res. 18, 313-25 (2015).
23. Xu, H. et al. A systems biology-based approach to uncovering the molecular mechanisms underlying the effects of dragon's blood tablet in colitis, involving the integration of chemical analysis, ADME prediction, and network pharmacology. PLoS One 9, e101432 (2014).
24. Haiyu, X. et al. Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach. Mol Biosyst. 12, 233-45 (2016).
25. Zhang, Y. et al. A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma. Sci Rep. 4, 4154 (2014).
26. Mackay, I. R. Hepatoimmunology: A perspective. Immunol Cell Biol. 80, 36-44 (2002).
27. Sachdeva, M., Chawla, Y. K. & Arora, S. K. Immunology of hepatocellular carcinoma. World J Hepatol. 7, 2080-90 (2015).
28. Nakanishi, H. et al. Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites. J Gastroenterol. In press (2015).
29. Jonassen, T. E. et al. Renal water handling in mice with decompensated liver cirrhosis. Am J Physiol Renal Physiol. 279, F1101-9 (2000).
30. Jonassen, T. E., Nielsen, S., Christensen, S. & Petersen, J. S. Decreased vasopressin-mediated renal water reabsorption in mice with compensated liver cirrhosis. Am J Physiol. 275, F216-25 (1998).
31. Asahina, Y. et al. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology. 21, 169-73 (1995).
32. Shi, Q. et al. FRK Inhibits Migration and Invasion of Human Glioma Cells by Promoting N-cadherin/-catenin Complex Formation. J Mol Neurosci. 55, 32-41 (2015).
33. Annerén, C., Welsh, M. & Jansson, L. Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter. Am J Physiol Endocrinol Metab. 292, E1183-90 (2007).
34. Chen, J. S., Hung, W. S., Chan, H. H., Tsai, S. J. & Sun, H. S. In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma. Bioinformatics. 29, 420-7 (2013).
35. Zhang, Y. & Zhang, B. D4-GDI, a Rho GTPase Regulator, Promotes Breast Cancer Cell Invasiveness. Cancer Res. 66, 5592-8 (2006).
36. Kondoh, K. et al. Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphatedissociation inhibitor (D4-GDI). Int Immunol. 20, 1299-311 (2008).
37. Fang, Y., Yi, J., Lizhi, L. & Qiucheng, C. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma. DNA Cell Biol. 33, 781-6 (2014).
38. Tarasenko, T. et al. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci USA 104, 11382-7 (2007).
39. MacGlashan, D. W., Jr. Relationship between spleen tyrosine kinase and phosphatidylinositol 5sphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol. 119, 626-33 (2007).
40. Sumie, S. et al. Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. Oncol Rep. 18, 545-52 (2007).
41. Nielsen, S., DiGiovanni, S. R., Christensen, E. I., Knepper, M. A. & Harris, H. W. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc. Proc Natl Acad Sci USA 90, 11663-7 (1993).
42. Tamma, R. et al. Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc Natl Acad Sci USA 110, 18644-9 (2013).
43. Sakaida, I. Tolvaptan for the treatment of liver cirrhosis oedema. Expert Rev Gastroenterol Hepatol. 8, 461-70 (2014).
44. Watson, H. et al. Satavaptan treatment for ascites in patients with cirrhosis: A meta-analysis of effect on hepatic encephalopathy development. Metab Brain Dis. 28, 301-5 (2013).
45. Kitchen, P. & Conner, A. C. Control of the Aquaporin-4 Channel Water Permeability by Structural Dynamics of Aromatic/Arginine Selectivity Filter Residues. Biochemistry 54, 6753-5 (2015).
46. Wright, G. et al. Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol. 53, 91-7 (2010).
47. Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447-52 (2015).
48. Wixon, J. & Kell, D. The Kyoto encyclopedia of genes and genomes-KEGG. Yeast. 17, 48-55 (2000).
49. Ballester, M., Castelló, A., Ibáñez, E., Sánchez, A. & Folch, J. M. Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. Biotechniques 37, 610-3 (2004).
50. Kong, X. et al. Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade. PLoS One 8, e77513 (2013).
51. Lin, N. et al. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol. 73, 136-46 (2007).